MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,800,500 | +426.2% | 82,000 | +17.8% | 0.55% | +387.6% |
| Q3 2022 | $4,523,000 | +1753.7% | 69,600 | +2312.5% | 0.11% | +1783.3% |
| Q4 2021 | $244,000 | -1.6% | 2,885 | +13.5% | 0.01% | -25.0% |
| Q2 2021 | $248,000 | -13.9% | 2,542 | +3.2% | 0.01% | -27.3% |
| Q1 2021 | $288,000 | +10.3% | 2,464 | +5.1% | 0.01% | +10.0% |
| Q4 2020 | $261,000 | -6.1% | 2,345 | 0.0% | 0.01% | -41.2% |
| Q3 2020 | $278,000 | -87.2% | 2,345 | -87.8% | 0.02% | -88.6% |
| Q2 2020 | $2,178,000 | +39.3% | 19,235 | -17.9% | 0.15% | +14.6% |
| Q1 2020 | $1,564,000 | +11.3% | 23,423 | +51.9% | 0.13% | +6.6% |
| Q4 2019 | $1,405,000 | +60.4% | 15,423 | +51.8% | 0.12% | +52.5% |
| Q3 2019 | $876,000 | -24.3% | 10,157 | -8.0% | 0.08% | -23.8% |
| Q2 2019 | $1,157,000 | -5.8% | 11,039 | +12.6% | 0.10% | -11.8% |
| Q1 2019 | $1,228,000 | – | 9,800 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |